Biologics Digitalization & AI World 2026 (Non-SG/APAC Biopharma)

Be part of the 3rd Annual Biologics Digitalisation & AI World 2026, the leading platform in Asia spotlighting the transformative power of AI and digitalisation in biologics development and manufacturing.

‍With the global AI in biopharma development market projected to grow from USD 991.0 million in 2024 to USD 13.5 billion by 2034 (30% CAGR), the industry is accelerating its shift toward smarter, faster, and more efficient research, development, and production.

‍From in-silico drug screening to NLP-driven literature analysis and predictive modelling, AI is dramatically reducing discovery timelines and optimising drug design. Top pharma players are already leveraging these tools to gain a competitive edge.

‍Join senior-level innovators, digital leaders, and AI experts to explore real-world applications, regulatory trends, and strategies driving digital transformation in biologics.

‍Accelerate innovation. Enhance outcomes. Experience the future of biologics – powered by AI.